Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diabetes

  Free Subscription


30.12.2024

1 Am Heart J
1 Biochem Biophys Res Commun
2 BMC Ophthalmol
2 Diabet Med
2 Diabetes
1 Diabetes Care
8 Diabetes Obes Metab
1 Eur J Endocrinol
1 Invest Ophthalmol Vis Sci
1 JAMA
1 Kidney Int
1 Metabolism
1 Ophthalmology
1 PLoS Genet
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. NELSON AJ, Kaltenbach LA, McGuire DK, Levya M, et al
    Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.
    Am Heart J. 2024 Dec 21:S0002-8703(24)00336-3. doi: 10.1016/j.ahj.2024.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  2. XIA S, Wu L, Chen J, Li K, et al
    Low expression of Frataxin might contribute to diabetic peripheral neuropathy in a mouse model.
    Biochem Biophys Res Commun. 2024;744:151228.
    PubMed         Abstract available


    BMC Ophthalmol

  3. QUIROZ-REYES MA, Quiroz-Gonzalez EA, Quiroz-Gonzalez MA, Lima-Gomez V, et al
    Elucidating postoperative dynamics in tractional retinal detachment: a systematic review and meta-analysis of structural and functional outcomes following diabetic vitrectomy, including an analysis of postoperative complications.
    BMC Ophthalmol. 2024;24:547.
    PubMed         Abstract available

  4. WANG Z, Bai X, Wang M, Li F, et al
    Risk factors for diabetic retinopathy in young and middle-aged patients: a retrospective study.
    BMC Ophthalmol. 2024;24:544.
    PubMed         Abstract available


    Diabet Med

  5. CANHA D, McMahon V, Schmitz S, De Beaufort C, et al
    The effect of automated insulin delivery system use on diabetes distress in people with type 1 diabetes and their caregivers: A systematic review and meta-analysis.
    Diabet Med. 2024 Dec 26:e15503. doi: 10.1111/dme.15503.
    PubMed         Abstract available

  6. ERCOLINO GT, Sprinkles J, Fruik A, Muthukkumar R, et al
    Disordered eating attitudes and behaviours among older adults with type 1 diabetes: An exploratory study.
    Diabet Med. 2024 Dec 22:e15504. doi: 10.1111/dme.15504.
    PubMed         Abstract available


    Diabetes

  7. MARCHIORI M, Maguolo A, Perfilyev A, Maziarz M, et al
    Blood-based epigenetic biomarkers associated with incident chronic kidney disease in individuals with type 2 diabetes.
    Diabetes. 2024 Dec 23:db240483. doi: 10.2337/db24-0483.
    PubMed         Abstract available

  8. NISHIKAWA K, Murakami T, Yoshida M, Terada N, et al
    Extracellular Mitochondria Exacerbate Retinal Pigment Epithelium Degeneration in Diabetic Retinopathy.
    Diabetes. 2024 Dec 23:db240040. doi: 10.2337/db24-0040.
    PubMed         Abstract available


    Diabetes Care

  9. KIM SE, Han K, Cho WK, Suh BK, et al
    Cardiovascular Complications, Kidney Failure, and Mortality in Young-Onset Type 1 and 2 Diabetes: Data From the Korean National Health Insurance Service.
    Diabetes Care. 2024 Dec 23:dc241023. doi: 10.2337/dc24-1023.
    PubMed         Abstract available


    Diabetes Obes Metab

  10. ZHAO X, Xu X, Wang S, Zhang X, et al
    Heterogeneous blood pressure treatment effects on cognitive decline in type 2 diabetes: A machine learning analysis of a randomized clinical trial.
    Diabetes Obes Metab. 2024 Dec 26. doi: 10.1111/dom.16145.
    PubMed         Abstract available

  11. XU Z, Wen S, Dong M, Zhou L, et al
    Targeting central pathway of Glucose-Dependent Insulinotropic Polypeptide, Glucagon and Glucagon-like Peptide-1 for metabolic regulation in obesity and type 2 diabetes.
    Diabetes Obes Metab. 2024 Dec 26. doi: 10.1111/dom.16146.
    PubMed         Abstract available

  12. BORYSOWSKI J, Klosowska D, Paczek L, Ordak M, et al
    Exclusion of older persons from randomized controlled trials in type 2 diabetes: A cross-sectional study.
    Diabetes Obes Metab. 2024 Dec 26. doi: 10.1111/dom.16137.
    PubMed         Abstract available

  13. TAKAHASHI A, Nomoto H, Yokoyama H, Yokozeki K, et al
    Efficacy of imeglimin treatment versus metformin dose escalation on glycemic control in subjects with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: A multicenter, prospective, randomized, open-label, parallel
    Diabetes Obes Metab. 2024 Dec 26. doi: 10.1111/dom.16150.
    PubMed         Abstract available

  14. FUKUNAGA K, Morishita A, Imachi H, Oura K, et al
    Efficacy of imeglimin in patients with type 2 diabetes mellitus complicated by metabolic dysfunction-associated steatotic liver disease: A multicentre study.
    Diabetes Obes Metab. 2024 Dec 26. doi: 10.1111/dom.16157.
    PubMed         Abstract available

  15. WONG HJ, Lin NHY, Teo YH, Yeo BSY, et al
    Anti-diabetic effects of GLP-1 receptor agonists on obese and overweight patients across diabetes status, administration routes, treatment duration and baseline characteristics: A systematic review.
    Diabetes Obes Metab. 2024 Dec 26. doi: 10.1111/dom.16136.
    PubMed         Abstract available

  16. BAECHLE C, Rosenbauer J, Stahl-Pehe A, Seufert J, et al
    Effectiveness of add-on therapy with SGLT2 inhibitors or GLP-1 receptor agonists in adults with type 1 diabetes: A prospective DPV registry study.
    Diabetes Obes Metab. 2024 Dec 27. doi: 10.1111/dom.16149.
    PubMed        

  17. XIE C, Iroga P, Bound MJ, Grivell J, et al
    Impact of the timing of metformin administration on the plasma lactate response to intraduodenal glucose infusion in type 2 diabetes.
    Diabetes Obes Metab. 2024 Dec 27. doi: 10.1111/dom.16169.
    PubMed        


    Eur J Endocrinol

  18. ROBLEDO KP, Marschner IC, Grossmann M, Handelsman DJ, et al
    Predicting Type 2 Diabetes and Testosterone Effects in high-risk Australian men: Development and external validation of a 2 year risk model.
    Eur J Endocrinol. 2024 Dec 25:lvae166. doi: 10.1093.
    PubMed         Abstract available


    Invest Ophthalmol Vis Sci

  19. SUGASINI D, Yalagala PCR, Park JC, Ma G, et al
    Retinal Docosahexaenoic Acid Is Significantly Reduced in Diabetic Humans and Mice: Possible Relationship to Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2024;65:39.
    PubMed         Abstract available


    JAMA

  20. LIMONTE CP, Pilla SJ, de Boer IH
    Diabetes and Chronic Kidney Disease.
    JAMA. 2024 Dec 26. doi: 10.1001/jama.2024.24671.
    PubMed        


    Kidney Int

  21. MIMURA I, Chen Z, Natarajan R
    Epigenetic alterations and memory: key players in the development/progression of chronic kidney disease promoted by acute kidney injury and diabetes.
    Kidney Int. 2024 Dec 24:S0085-2538(24)00918-9. doi: 10.1016/j.kint.2024.
    PubMed         Abstract available


    Metabolism

  22. DOU C, Liu D, Kong L, Chen M, et al
    Shared genetic architecture of type 2 diabetes with muscle mass and function and frailty reveals comorbidity etiology and pleiotropic druggable targets.
    Metabolism. 2024 Dec 20:156112. doi: 10.1016/j.metabol.2024.156112.
    PubMed         Abstract available


    Ophthalmology

  23. BAI WH, Bai YC, Wei JC
    Re: Muayad et al.: Comparative effects of GLP-1 receptor agonists and metformin on glaucoma risk in patients with type 2 diabetes (Ophthalmology. 2024 Aug 23:S0161-6420(24)00515-3).
    Ophthalmology. 2024 Dec 21:S0161-6420(24)00743.
    PubMed        


    PLoS Genet

  24. MORA-BITRIA L, Debebe BJ, Miners KL, Ladell K, et al
    Inhibitory KIRs decrease HLA class II-mediated protection in Type 1 Diabetes.
    PLoS Genet. 2024;20:e1011456.
    PubMed         Abstract available


    PLoS One

  25. HADID D, Correia RH, McDonald SD, Darling EK, et al
    Assessing the impact of the COVID-19 pandemic on uptake and experiences of gestational diabetes mellitus screening in Ontario: A parallel convergent mixed-methods study.
    PLoS One. 2024;19:e0315983.
    PubMed         Abstract available


  26. Expression of Concern: Urinary Exosomal microRNA-451-5p Is a Potential Early Biomarker of Diabetic Nephropathy in Rats.
    PLoS One. 2024;19:e0316405.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.